Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pepke

Showing results (231-240 of 316) with videos related to

Pageof 32
Sort By:
Open Heart|June 8, 2026
Comparing bridging drug therapy approaches prior to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a prospective analysis from the national UK CURATE registryOliver M Li, Hakim Ghani, Paula Appenzeller, et al.
Journal of the American College of Cardiology|December 20, 2008
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trialXavier Jaïs, Andrea M D'Armini, Pavel Jansa, et al.
Pulmonary Circulation|March 4, 2026
The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of LifeKatherine Bunclark, Joseph Newman, Hakim Ghani, et al.
Chest|January 22, 2022
Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on SurvivalMax Schwiening, Emilia M Swietlik, Divya Pandya, et al.
Circulation|August 18, 2010
Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertensionElaine Soon, Alan M Holmes, Carmen M Treacy, et al.
The European Respiratory Journal|November 10, 2018
Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertensionEmilia Maria Swietlik, Alessandro Ruggiero, Andrew J Fletcher, et al.
Chest|December 2, 2024
Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular ComorbiditiesR James White, Karim El-Kersh, Stephan Rosenkranz, et al.
The European Respiratory Journal|June 10, 2020
CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertensionMichael Newnham, Katherine Bunclark, Nisha Abraham, et al.
Pulmonary Circulation|March 4, 2026
The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3Katherine Bunclark, Joseph Newman, Hakim Ghani, et al.
Pulmonary Circulation|December 26, 2022
Acute lung injury after balloon pulmonary angioplasty results in a similar haemodynamic response and possible clinical advantage at follow-upMatthew S Rodgers, Louise C Kirkby, Liliana Amaral-Almeida, et al.
Pageof 32

Showing results (231-240 of 316) with videos related to

Sort By:
Pageof 32
Open Heart|June 8, 2026
Comparing bridging drug therapy approaches prior to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a prospective analysis from the national UK CURATE registryOliver M Li, Hakim Ghani, Paula Appenzeller, et al.
Journal of the American College of Cardiology|December 20, 2008
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trialXavier Jaïs, Andrea M D'Armini, Pavel Jansa, et al.
Pulmonary Circulation|March 4, 2026
The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of LifeKatherine Bunclark, Joseph Newman, Hakim Ghani, et al.
Chest|January 22, 2022
Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on SurvivalMax Schwiening, Emilia M Swietlik, Divya Pandya, et al.
Circulation|August 18, 2010
Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertensionElaine Soon, Alan M Holmes, Carmen M Treacy, et al.
The European Respiratory Journal|November 10, 2018
Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertensionEmilia Maria Swietlik, Alessandro Ruggiero, Andrew J Fletcher, et al.
Chest|December 2, 2024
Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular ComorbiditiesR James White, Karim El-Kersh, Stephan Rosenkranz, et al.
The European Respiratory Journal|June 10, 2020
CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertensionMichael Newnham, Katherine Bunclark, Nisha Abraham, et al.
Pulmonary Circulation|March 4, 2026
The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3Katherine Bunclark, Joseph Newman, Hakim Ghani, et al.
Pulmonary Circulation|December 26, 2022
Acute lung injury after balloon pulmonary angioplasty results in a similar haemodynamic response and possible clinical advantage at follow-upMatthew S Rodgers, Louise C Kirkby, Liliana Amaral-Almeida, et al.
Pageof 32